ArticleThe Lancet regional health. Western Pacific2021
Suspension of proactive recommendations for HPV vaccination has led to a significant increase in HPV infection rates in young Japanese women: real-world data.
Article in The Lancet regional health. Western Pacific, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Factors Associated with Human Papillomavirus Vaccination Intention Among Young Men in Japan: A Cross-Sectional Study.Journal of community health · 2026Article
- Article
- A ninth-year follow-up survey of attitudes and behaviors of obstetricians and gynecologists toward HPV vaccination in Japan.Scientific reports · 2025Article
- Effect of information awareness on attitudes toward human papillomavirus vaccination intentions in Japan.Vaccine: X · 2025Article
- Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region.Human vaccines & immunotherapeutics · 2024Review
- Questionnaire survey on cervical cancer screening and HPV awareness among patients at a local cancer center in Japan.BMC women's health · 2024Article
- Even though active recommendation for HPV vaccination has restarted, Japan's rates have not recovered.Cancer science · 2024Article
- Human Papillomavirus Vaccination by Birth Fiscal Year in Japan.JAMA network open · 2024Article
- Effectiveness of catch-up and routine program of the 9-valent vaccine on cervical cancer risk reduction in Japan.Cancer science · 2024Article
- A comprehensive narrative review of challenges and facilitators in the implementation of various HPV vaccination program worldwide.Cancer medicine · 2024Review
- Information-seeking Behavior of Iranian Young Adults (18-28 Years Old) Regarding HPV on Social Media: A Preventive Approach to HPV.International journal of preventive medicine · 2024Article
- Intentions for catch-up HPV vaccination in Japan: an internet survey.International journal of clinical oncology · 2023Article
- Etiology, diagnosis, treatment, and prevention of human papilloma virus-associated oropharyngeal squamous cell carcinoma.International journal of clinical oncology · 2023Review
- Disparities among Japanese municipalities in recommendations for routine and catch-up HPV vaccinations.Cancer science · 2023Article
- Updates on HPV Vaccination.Diagnostics (Basel, Switzerland) · 2023Review
- Can Catch-Up Vaccinations Fill the Void Left by Suspension of the Governmental Recommendation of HPV Vaccine in Japan?Vaccines · 2022Article
- Effectiveness of human papillomavirus vaccine against cervical precancer in Japan: Multivariate analyses adjusted for sexual activity.Cancer science · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.